AIM ImmunoTech (AIM) Q1 2025 Earnings
AIM·Reported May 15, 2025·Before market open
AIM ImmunoTech reported Q1 2025 revenue of $16.0K (-60.0% YoY). Diluted EPS came in at $-5.00 (+58.3% YoY), beat the $-8.00 consensus by $3.00.
Revenue
$16.0K
Diluted EPS
$-5.00beat by $3.00
Consensus: $-8.00
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about AIM ImmunoTech's Q1 2025 earnings report.
AIM ImmunoTech (AIM) reported Q1 2025 earnings on May 15, 2025 before market open.
AIM ImmunoTech reported revenue of $16.0K and diluted EPS of $-5.00 for Q1 2025.
EPS beat the consensus estimate of $-8.00 by $3.00.
Compared to the same quarter a year prior, revenue declined 60.0% from $40.0K a year earlier and diluted EPS grew 58.3% from $-12.00.
You can read the 10-Q periodic report (0001641172-25-011033) directly on SEC EDGAR. The filing index links above go to sec.gov.